ロード中...
Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects
AIMS: To evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of CHF3381, a dual NMDA and MAO-A inhibitor, after multiple oral doses in healthy subjects. METHODS: Forty-eight young males received CHF3381 at doses of 100 mg twice daily, 200 mg twice daily, 400 mg twice dail...
保存先:
主要な著者: | , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Blackwell Science Inc
2005
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1884805/ https://ncbi.nlm.nih.gov/pubmed/15801935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02338.x |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|